1. Medtech Insight
  2. >>Business
  3. >>Startups & SMEs

Start-Up Spotlight: Raising The Odds For IVF Success, Univfy Brings Algorithms To Fertility Clinics

 
• By Marion Webb

Silicon Valley-based start-up Univfy has developed a machine-learning platform that helps in vitro fertilization clinics better predict the chances of IVF success for individual couples, and, with that, improve access to IVF treatment and financing. For 2019, Univfy hopes to use machine learning to expand its current capabilities from improving a couple's access to a clinic's refund program to coaching and breaking down other cost barriers.

Start-up Spotlight

For millions of couples who have trouble conceiving, in vitro fertilization is often the best hope for realizing their dream of becoming pregnant. But the high treatment costs, let alone the physical and emotional toll involved in undergoing IVF treatment, can deter many couples from even trying.

Silicon Valley-based start-up Univfy hopes to change that by helping couples attain easier access to IVF treatment and financing.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Startups & SMEs

Ultromics Wins $55M, The Key To Success: Diagnosing Diseases With Available Treatment

 
• By Natasha Barrow

Ultromics has secured $55m in Series C funding to advance its AI tool, EchoGo, which detects undiagnosed heart failure. The company's focus on diseases with available treatments resonated with investors.

IMMA’s At-Home Ultrasound Tool Eases IVF Journey

 
• By Ashley Yeo

IMMA’s transvaginal at-home ovarian stimulation monitoring system using ultrasound and AI image analysis increases the chances of early IVF success. It won the Biomed Israel 2025 IVD start-up showcase award. Further potential applications could follow, cofounder/CEO Beatrice Chemla said.

FDA’s Small Business Eligibility Process Gets Update Before New Fiscal Year

 
• By Elizabeth Orr

The US FDA has updated its guidance document on small business eligibility determinations for medical device firms. Industry observers urge companies to ask for the status early to avoid any potential hold-ups.

NHS Orders Halt On Unapproved AI Scribes, Vendors Rush To Self-Certify

 
• By Natasha Barrow

NHS England's national chief clinical information officer issued a cease and desist on unapproved ambient voice technology and AI scribes. The move caused confusion among AVT vendors and went beyond joint MHRA/NHS guidance. IMed consultant Ben Austin shares his perspective.

More from Business

IMMA’s At-Home Ultrasound Tool Eases IVF Journey

 
• By Ashley Yeo

IMMA’s transvaginal at-home ovarian stimulation monitoring system using ultrasound and AI image analysis increases the chances of early IVF success. It won the Biomed Israel 2025 IVD start-up showcase award. Further potential applications could follow, cofounder/CEO Beatrice Chemla said.

Siemens Healthineers Mitigates Headwinds With ‘Value-Add Structural Changes’

 
• By Natasha Barrow

Siemens Healthineers anticipates €400m-€500m tariff impact by 2026 but says it will mitigate losses through structural changes and pricing. Despite a revenue decline in diagnostics due to China’s VBP, diagnostics transformation activities, including cutting product, were “successful."

GE HealthCare Halves 2025 Tariff EPS Hit As Global Supply Chain Realigns

 
• By Shubham Singh

For the third quarter of 2025, GE HealthCare projects year-over-year organic revenue growth in the range of 2%-3%. However, adjusted EPS is expected to decline in the high single digits year-over-year, reflecting the ongoing effect of tariff costs.